Karen Bloch honored for clinical excellence by Infectious Diseases Society of America

Vanderbilt’s Karen Bloch, MD, MPH, is one of two winners of the 2023 Watanakunakorn Clinician Award from the Infectious Disease Society of America.

Study finds most infants receiving ICU-level care for RSV had no underlying medical condition

A Vanderbilt study found that most infants admitted to the intensive care or high acuity unit for respiratory syncytial virus (RSV) infections during fall 2022 were previously healthy and born at term.

Research Staff Awards honor contributions to discovery

High-dose flu vaccine beneficial for pediatric stem cell transplant patients

Vanderbilt was the lead site for an influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population.

Infectious disease expert Edwards ends storied career

Vanderbilt’s Kathryn Edwards, MD, internationally recognized for her countless contributions to vaccine evaluation and implementation, public health advocacy, and the mentorship and training of new generations of experts in infectious disease over the past four decades, retired on Dec. 31, 2022.

Improving awareness and understanding of antimicrobial resistance is crucial

The Vanderbilt Antimicrobial Stewardship Program provides oversight of antimicrobial therapies for both inpatient and outpatient populations.